What is Pheochromocytoma

TL;DR: Pheochromocytoma is a rare, usually noncancerous tumor that develops in the adrenal glands, causing them to release excess hormones that trigger high blood pressure, headaches, and rapid heart rate. While these tumors are often benign, they require specialized medical management because the surge of hormones can lead to serious cardiovascular complications if left untreated.

What exactly is a Pheochromocytoma?

A Pheochromocytoma is a rare neuroendocrine tumor that arises from chromaffin cells located in the medulla (the center) of the adrenal glands. When a Pheochromocytoma develops, it acts like a "rogue" gland, intermittently or persistently secreting high levels of catecholamines—specifically adrenaline (epinephrine) and noradrenaline (norepinephrine). These hormones are responsible for the body’s "fight or flight" response, which explains why individuals with this condition often experience symptoms that mimic intense anxiety or panic attacks, despite the underlying cause being physiological rather than psychological.

Which body systems are affected by Pheochromocytoma?

Because adrenaline and noradrenaline circulate throughout the bloodstream, a Pheochromocytoma can affect nearly every organ system, though the cardiovascular system bears the greatest burden. The excess hormones cause blood vessels to constrict and the heart to beat faster and harder. Key impacts include:

• Cardiovascular: Persistent or paroxysmal (sudden, severe) high blood pressure, palpitations, and in rare cases, heart muscle damage.


• Neurological: Severe, pounding headaches, often accompanied by excessive sweating and tremor.


• Metabolic: Potential for hyperglycemia (high blood sugar) as the hormones interfere with insulin production.


• Gastrointestinal: Nausea, abdominal pain, or unintentional weight loss.

How common is this condition and who is affected?

Pheochromocytoma is considered rare, with an estimated annual incidence of approximately 2 to 8 cases per million people. It is most frequently diagnosed in adults between the ages of 30 and 50, though it can occur at any age. There is no significant gender bias, as it affects men and women with equal frequency. While most cases are sporadic (occurring by chance), approximately 25% to 30% of patients have an underlying hereditary genetic mutation. This is why genetic testing is often recommended for those diagnosed with a Pheochromocytoma to screen for associated syndromes like Multiple Endocrine Neoplasia (MEN) type 2, Von Hippel-Lindau disease, or Neurofibromatosis type 1.

What differentiates Pheochromocytoma from other conditions?

It is important to distinguish Pheochromocytoma from "Paraganglioma." While both are catecholamine-secreting tumors, a Pheochromocytoma is strictly confined to the adrenal glands, whereas paragangliomas arise from similar cells located outside the adrenal glands, often along nerve pathways in the abdomen, chest, or neck. Unlike common essential hypertension, the high blood pressure associated with this condition is often resistant to standard medications and is frequently accompanied by the "classic triad" of symptoms: headaches, palpitations, and sweating.

Next steps

• Consult an endocrinologist or a specialist in neuroendocrine tumors to discuss biochemical testing (blood or urine tests for metanephrines).


• Request a referral to a clinical geneticist, especially if you have a family history of endocrine tumors.


• Join the DiseaseMaps.org community to connect with 165 other members who are sharing their experiences with Pheochromocytoma.


• Maintain a detailed log of your blood pressure readings and symptom episodes to assist your medical team in diagnosis and treatment planning.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Pheochromocytoma.


• Orphanet: Pheochromocytoma (ORPHA:706).


• OMIM (Online Mendelian Inheritance in Man): Pheochromocytoma entry #171300.


• Endocrine Society Clinical Practice Guideline: Diagnosis and Management of Pheochromocytoma and Paraganglioma.